Page last updated: 2024-10-15

gamma-aminobutyric acid and Epileptic Syndromes

gamma-aminobutyric acid has been researched along with Epileptic Syndromes in 2 studies

gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.

Epileptic Syndromes: EPILEPTIC SEIZURES that are of similar type and age of onset and have other similar features (e.g., clinical course, EEG findings, genetic association and neuropathology).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Tanenhaus, A1
Stowe, T1
Young, A1
McLaughlin, J1
Aeran, R1
Lin, IW1
Li, J1
Hosur, R1
Chen, M1
Leedy, J1
Chou, T1
Pillay, S1
Vila, MC1
Kearney, JA1
Moorhead, M1
Belle, A1
Tagliatela, S1
Miljanovic, N1
van Dijk, RM1
Buchecker, V1
Potschka, H1

Other Studies

2 other studies available for gamma-aminobutyric acid and Epileptic Syndromes

ArticleYear
Cell-Selective Adeno-Associated Virus-Mediated
    Human gene therapy, 2022, Volume: 33, Issue:11-12

    Topics: Animals; Dependovirus; Disease Models, Animal; Epilepsies, Myoclonic; Epileptic Syndromes; gamma-Ami

2022
Metabolomic signature of the Dravet syndrome: A genetic mouse model study.
    Epilepsia, 2021, Volume: 62, Issue:8

    Topics: Animals; Bile Acids and Salts; Disease Models, Animal; Epilepsies, Myoclonic; Epileptic Syndromes; g

2021